Reports & publications

Paul is the Founding CEO of Inizio, where he shaped the company’s vision and led its growth for four transformative years before stepping into his current role as Advisor. Prior to this, Paul was appointed as CEO of Huntsworth plc in April 2015. He turned Huntsworth into a leading healthcare advisory business before taking the company private under CD&R. Before this, Paul enjoyed a 20-year career in London and New York with Hill & Knowlton Inc., the global communications consultancy and subsidiary of WPP plc, including nine years as its Chairman and CEO. During this time, Paul advised numerous blue-chip and international clients across all geographies and sectors. 

Ryan was appointed CEO of Inizio in September 2025, following a four-year tenure as COO, during which he provided strategic leadership across global divisions. In this role, he worked closely with executive management teams to establish and deliver long-term strategic growth plans. Before this, Ryan was COO at UDG Healthcare. He brings over 25 years of experience in the pharmaceutical industry, holding senior commercial leadership roles. Prior to joining UDG Healthcare, Ryan served as Regional Vice President, Region South, and Immunology and HCV Lead for AbbVie Western Europe and Canada. 

Colin is Inizio’s Chief Commercial Officer and is responsible for our Commercial Activities and Business Development, with a particular emphasis on the support of our Large Enterprise Accounts and the infrastructure that supports our Global Sales Team. Prior to his current role, he was President of Inizio Advisory from September 2019, where he oversaw Inizio’s Consulting and Research Businesses. Before Inizio, Colin spent 20 years at ICON, where he held several leadership positions, including President of ICON Functional Services. Colin is a seasoned leader in the pharma industry, bringing 30 years of experience across both clinical development and commercialization. He has a strong track record of driving business growth, both organically and through M&A, and improving margins through process optimization. 

Joining Ashfield in 2005 as a Regional Account Director in the UK, Greg Flynn has since worked with our teams across the UK, Japan and the US. He established and ran our joint venture in Japan before moving to the US in 2017 to lead Engage. Greg was previously the President of Engage from 2019 - 2025.

Reid Connolly leads Inizio Evoke, a global health marketing, communications, and transformation platform dedicated to making health more human™. Since founding Evoke in 2006, Reid has been instrumental in evolving the agency into one of the most progressive, client-centric, and people-first agencies in the industry, embracing its digital and data-driven roots to create a uniquely integrated platform. Reid has also been recognized by PRWeek as one of the industry’s top voices, with honors on both the Health Influencer 50 and Health Influencer 30 lists. Prior to founding Evoke, Reid held senior leadership roles at Digitas Health, imc2, and Saatchi & Saatchi Healthcare, where he honed his expertise in integrated healthcare marketing. He has partnered with leading pharmaceutical and biotech companies, including AstraZeneca, Amgen, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Novartis, and Pfizer.

Joining Medistrava in 2015, Elaine helped double the size of the organization through organic growth and acquisition to create a fully integrated medical, health economics and market access platform. Now, she joins us as President of Inizio Medical. As a trained neuropsychologist, Elaine has enjoyed a career in research and clinical practice before joining the industry, combining her background in science and behavior to drive evidence-based strategies that apply to real-world healthcare challenges.